LTFS
EGRX

Ladenburg Thalmann Financial Services’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$7K Sell
113
-9
-7% -$537 ﹤0.01% 4661
2019
Q3 		$7K Buy
122
+80
+190% +$4.5K ﹤0.01% 4562
2019
Q2 		$2K Hold
42
– – ﹤0.01% 5019
2019
Q1 		$2K Sell
42
-33
-44% -$1.47K ﹤0.01% 4981
2018
Q4 		$3K Sell
75
-67
-47% -$3.45K ﹤0.01% 4813
2018
Q3 		$10K Sell
142
-3,257
-96% -$247K ﹤0.01% 4304
2018
Q2 		$178K Hold
3,399
– – ﹤0.01% 2325
2018
Q1 		$178K Buy
3,399
+50
+1% +$2.91K ﹤0.01% 2325
2017
Q4 		$179K Hold
3,349
– – ﹤0.01% 2285
2017
Q3 		$203K Buy
3,349
+31
+0.9% +$1.88K ﹤0.01% 2099
2017
Q2 		$261K Buy
3,318
+18
+0.5% +$1.47K ﹤0.01% 1825
2017
Q1 		$274K Hold
3,300
– – ﹤0.01% 1692
2016
Q4 		$262K Hold
3,300
– – ﹤0.01% 1637
2016
Q3 		$231K Sell
3,300
-50
-1% -$2.77K ﹤0.01% 1664
2016
Q2 		$132K Buy
3,350
+3,300
+6,600% +$137K ﹤0.01% 1957
2016
Q1 		$2K Hold
50
– – ﹤0.01% 4414
2015
Q4 		$4K Buy
+50
New +$3.95K ﹤0.01% 4159
2015
Q3 		– Sell
-405
Closed -$33K – 4757
2015
Q2 		$33K Buy
+405
New +$26.4K ﹤0.01% 2885

Other funds holding EGRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Ladenburg Thalmann Financial Services's EGRX Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Eagle Pharmaceuticals, Inc. (EGRX) stake by 7.4% in Q4 2019, selling an estimated $537 and leaving 113 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #4661.

Ladenburg Thalmann Financial Services first reported a position in EGRX in Q2 2015 and has held it in 18 quarters since. The position peaked at $274K in Q1 2017. 176 funds tracked by Wall St. Rank hold EGRX as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 113 shares of Eagle Pharmaceuticals, Inc. worth $7K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 9 Eagle Pharmaceuticals, Inc. shares in Q4 2019, an estimated $537.
  • Eagle Pharmaceuticals, Inc. made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4661 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2015 and has held it in 18 quarters since.
  • Ladenburg Thalmann Financial Services's Eagle Pharmaceuticals, Inc. position peaked at $274K in Q1 2017.
  • 176 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.